Riskpilot← Back to searchSign inGet full accessPERVITAM AS
ASActiveOrg 913504313Skrivarvegen 12, 5417 StordOther human health activities n.e.c. · NACE 8699Est. 20140 employees
Revenue 2025
NOK 0
EBITDA margin
—
-3870% vs 2024
Equity ratio
-90468.2%
Financial strength
Net profit 2025
NOK -38K
-3870% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -38K | -3870% |
| Net profit | NOK -38K | -3870% |
| Total assets | NOK 44 | -98% |
| Equity | NOK -40K | -1806% |
| Employees | 0 | — |
Legal name
PERVITAM AS
Org number
913504313
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
14. april 2014
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Konsulentvirksomhet, undervisning og annen virksomhet som naturlig hører sammen med dette. Videre kan selskapet delta i andre selskap som driver liknende virksomhet, kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Skrivarvegen 12, 5417 Stord
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 312 | 463 | 191 | 80 | 0 | 9 | 0 | 11 | 0 | 0 | 0 | 0 |
| Staff expenses | −95 | −303 | −139 | −44 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 128 | −73 | −12 | −32 | −2 | 6 | −3 | −7 | −2 | 0 | −1 | −38 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 128 | −73 | −12 | −32 | −2 | 6 | −3 | −7 | −2 | 0 | −1 | −38 |
| Net financials | 0 | −0 | 0 | 0 | −0 | −0 | −0 | 0 | −0 | 0 | 0 | 0 |
| Profit before tax | 128 | −74 | −12 | −32 | −2 | 6 | −3 | −7 | −2 | 0 | −1 | −38 |
| Tax | 35 | 0 | 14 | −13 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 94 | −74 | −26 | −18 | −2 | 6 | −3 | −7 | −2 | 0 | −1 | −38 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 220 | 100 | 41 | 25 | 9 | 15 | 12 | 6 | 4 | 4 | 3 | 0 |
| Equity | 124 | 50 | 24 | 6 | 4 | 10 | 8 | 1 | −1 | −1 | −2 | −40 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 97 | 50 | 17 | 19 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 40 |
| Total debt | 97 | 50 | 17 | 19 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 40 |
EBITDA margin
-3771700.0%
This company
15.8%
Market median
-23871619% vs market
20142025
Equity ratio
-90468.2%
This company
38.2%
Market median
-236928% vs market
20142025
Return on equity
-3771700.0%
This company
18.4%
Market median
-20498470% vs market
20142025
Net profit margin
-3771700.0%
This company
8.1%
Market median
-46564298% vs market
20142025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20142025
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20142025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HF Deputy Member | Deputy Member | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2014 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PERVITAM AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Håkon Frode Særsten | Deputy Member | 0 companies |
| Gyri Åkra Nysæter | Chairman | 0 companies |